Caen, France

Herv E Prunier


Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Herv E. Prunier: Innovator in Medicinal Chemistry

Introduction

Herv E. Prunier is a prominent inventor based in Caen, France, known for his contributions to medicinal chemistry. With a focus on developing innovative compounds, Prunier has secured two patents that exhibit his commitment to advancing therapeutic options for various diseases.

Latest Patents

Prunier's most recent inventions include the development of tricyclic oxime ethers and tricyclic pyrrolopyrazine compounds. His first patent pertains to "Tricyclic oxime ethers," which are designed to provide new solutions for treating diseases that necessitate targeting selective serotonin reuptake sites along with 5-HT₂c or 5-HT₃ ligands. The compounds described in this patent are defined by a specific formula, showcasing their potential for therapeutic applications.

His second patent, titled "Tricyclic pyrrolopyrazine 5-HT₃-active compounds," focuses on a unique compound that is beneficial for treating disorders associated with 5-HT₃ receptors. This patent lays out a detailed formula, along with innovative medicinal products that could enhance treatment efficacy for related conditions.

Career Highlights

Prunier works with Adir et Compagnie, where he collaborates with other skilled professionals in the field of medicinal chemistry. His work reflects a commitment to innovation, and his patents underscore his ability to blend scientific expertise with practical applications in healthcare.

Collaborations

Throughout his career, Prunier has teamed up with notable colleagues such as Sylvain Rault and Max Robba. These collaborations enrich his research and development efforts, fostering an environment of creativity and teamwork in pursuit of groundbreaking medicinal solutions.

Conclusion

Herv E. Prunier stands out as an inventor whose work in medicinal chemistry demonstrates the power of innovation in addressing healthcare challenges. Through his patents and collaborations at Adir et Compagnie, Prunier continues to make significant strides in developing therapeutic compounds that aim to improve patient outcomes. His achievements reflect a profound understanding of the complexities of medicinal chemistry while showcasing the importance of dedicated research and collaboration in driving medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…